Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Mediators Inflamm ; 2020: 3417329, 2020.
Article in English | MEDLINE | ID: mdl-32256191

ABSTRACT

BACKGROUND: Primary hyperparathyroidism (PHPT) is a common cause of secondary osteoporosis in postmenopausal women. Th17 lymphocytes and the released cytokine IL-17A play an important role in bone metabolism. Th17 cells have been shown to be activated by PTH, and peripheral blood T cells from patients affected with PHPT express higher levels of IL-17A mRNA than controls. AIM: To investigate circulating levels of IL-17A and the ratio RANKL/OPG, as markers of osteoclastogenesis, in 50 postmenopausal PHPT women compared with postmenopausal osteoporotic non-PHPT women (n = 20). RESULTS: Circulating levels of IL-17A were similarly detectable in most PHPT and non-PHPT osteoporotic women (12.9 (8.4-23.1) vs. 11.3 (8.3-14.3) pg/ml, median (range interquartile), P = 0.759), at variance with premenopausal women where IL-17A was undetectable. In PHPT women, any significant correlations could be detected between circulating IL-17A levels and PTH levels. Nonetheless, significant negative correlations between circulating IL-17A and ionized calcium levels (r = -0.294, P = 0.047) and urine calcium excretions (r = -0.300, P = 0.045) were found. Moreover, PHPT women were characterized by positive correlations between IL-17A levels and femur neck (r = 0.364, P = 0.021) and total hip (r = 0.353, P = 0.015) T-scores. Circulating IL-17A levels did not show any significant correlation with sRANKL, OPG, and sRANKL/OPG ratio in PHPT women. CONCLUSIONS: In postmenopausal PHPT women, circulating IL-17A levels were similar to those detected in postmenopausal non-PHPT women, showing a disruption of the relationship observed in postmenopausal osteoporosis among circulating PTH, sRANKL, OPG, IL-17A, and bone demineralization in postmenopausal PHPT women. The data support an osteogenic effect of IL-17A in postmenopausal PHPT women.


Subject(s)
Hyperparathyroidism, Primary/blood , Interleukin-17/blood , Postmenopause/blood , Aged , Calcium/blood , Calcium/urine , Female , Humans , Hyperparathyroidism, Primary/urine , Interleukin-17/urine , Middle Aged , Osteoprotegerin/blood , Osteoprotegerin/urine , Postmenopause/urine , Receptor Activator of Nuclear Factor-kappa B/blood , Receptor Activator of Nuclear Factor-kappa B/urine
2.
Biomarkers ; 19(7): 597-603, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25171769

ABSTRACT

Podocyte damage and loss together have an important role in the pathogenesis and progression of glomerulonephritis. Glomerulonephritis patients and healthy controls were enrolled in this study. Biochemical, clinical and experimental procedures included measurement of total urinary protein, renal biopsy and gene expression analysis of the receptor activator of NF-kappaB (RANK). The urinary mRNA levels of RANK were significantly higher in the glomerulonephritis group compared to the controls. The urinary RANK level of glomerular subtypes was correlated significantly with proteinuria. The calculated area of RANK mRNA levels under the curve was 0.61 for minimal change disease (MCD), 0.97 for membranous nephropathy (MN), 0.65 for IgA nephropathy (IgAN), 0.70 for lupus nephritis (LN) and 0.70 for focal segmental glomerulosclerosis (FSGS). The urinary mRNA of RANK might be used to differentiate histologic subtypes of glomerulonephritis, particularly between MCD and MN.


Subject(s)
Glomerulonephritis, Membranous/urine , Nephrosis, Lipoid/urine , RNA, Messenger/urine , Receptor Activator of Nuclear Factor-kappa B/urine , Adult , Area Under Curve , Biopsy , Case-Control Studies , Diagnosis, Differential , Female , Genetic Markers , Glomerulonephritis, Membranous/diagnosis , Glomerulonephritis, Membranous/genetics , Humans , Male , Middle Aged , Nephrosis, Lipoid/diagnosis , Nephrosis, Lipoid/genetics , Predictive Value of Tests , Proteinuria/diagnosis , Proteinuria/genetics , Proteinuria/urine , ROC Curve , Receptor Activator of Nuclear Factor-kappa B/genetics , Up-Regulation , Urinalysis
3.
Exerc Immunol Rev ; 18: 116-27, 2012.
Article in English | MEDLINE | ID: mdl-22876724

ABSTRACT

The T-cell subset Th17 is induced partly by interleukin (IL)-6 and activated by IL-23, and produces a proinflammatory cytokine IL-17. Since IL-6 increases dramatically following long-lasting endurance exercise, this response may also stimulate the induction of IL-17 and IL-23 after exercise. The aim of this study was to clarify the dynamics of IL-17 in association with endurance exercise-induced muscle damage and inflammatory responses. Fourteen male triathletes participated in a duathlon race consisting of 5 km of running, 40 km of cycling and 5 km of running. Venous blood and urine samples were collected before, immediately after 1.5 h and 3 h after the race. Plasma and urine were analyzed using enzyme-linked immunosorbent assays (ELISA). Haematological and biochemical variables such as neutrophil activation marker (myeloperoxidase: MPO), muscle damage marker (myoglobin: Mb) and soluble receptor activator of nuclear factor (NF)-KB ligand (sRANKL) were also determined to estimate the biological and pathological significance. Plasma concentrations oflL-6 (+26.0x), MPO (+3.2x) and Mb (+4.9x) increased significantly immediately after the race and IL-17 and IL-23 tended to increase. Furthermore, plasma concentrations of IL-12p40 and sRANKL increased significantly after the race. The measured parameters related to Thl 7 cytokines in the urinary output were closely correlated with each other and muscle damage marker. These findings suggest that IL-17 induced by IL-6 and activated by IL-23 or other IL-17 producing-cells and IL-23 might promote neutrophil activation and muscle damage following prolonged endurance exercise.


Subject(s)
Interleukin-17/immunology , Muscle, Skeletal/immunology , Neutrophil Activation , Physical Endurance/immunology , Th17 Cells/immunology , Adult , Enzyme-Linked Immunosorbent Assay , Exercise/physiology , Humans , Interleukin-12 Subunit p40/blood , Interleukin-12 Subunit p40/urine , Interleukin-17/blood , Interleukin-17/urine , Interleukin-23/blood , Interleukin-23/immunology , Interleukin-23/urine , Interleukin-6/blood , Interleukin-6/immunology , Interleukin-6/urine , Male , Muscle, Skeletal/injuries , Myoglobin/blood , Myoglobinuria/immunology , Peroxidase/blood , Peroxidase/urine , Receptor Activator of Nuclear Factor-kappa B/blood , Receptor Activator of Nuclear Factor-kappa B/urine
SELECTION OF CITATIONS
SEARCH DETAIL
...